Scoparone inhibits the development of hepatocellular carcinoma by modulating the p38 MAPK/Akt/NF‐κB signaling in nonalcoholic fatty liver disease mice
- Type
- Retraction
- Notice date
- 4/21/2025 0:00
- Journal
- Environmental Toxicology
- Publisher
- Wiley
- Notice DOI
- 10.1002/tox.24521
- Original paper DOI
- 10.1002/tox.23851